Regional EPO Deals: Large vs. Small Molecules

Two recent deals in the EPO space by Astellas and Takeda show how Japanese pharma is competing at top level for product rights outside its domestic market, and illustrate the heady terms that next-generation EPO candidates command. They're also another sign that regional dealmaking is back.